Allogeneic hematopoietic stem cell transplantation allows long-term complete remission and curability in high-risk Waldenström’s macroglobulinemia: results of a retrospective analysis of the Société Française de Greffe de Moelle et de Thérapie Cellulaire
Background Patients with poor-risk Waldenström’s macroglobulinemia have suboptimal response and early post-treatment relapse with conventional therapies. Hence, new therapeutic approaches such as allogeneic stem cell transplantation should be evaluated in these patients.Design and Methods We examin...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
June, 2010
|
| In: |
Haematologica, the hematology journal
Year: 2010, Jahrgang: 95, Heft: 6, Pages: 950-955 |
| ISSN: | 1592-8721 |
| DOI: | 10.3324/haematol.2009.017814 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.3324/haematol.2009.017814 Verlag, kostenfrei, Volltext: https://haematologica.org/article/view/5632 
|
| Verfasserangaben: | Alice Garnier, Marie Robin, Fabrice Larosa, Jean-Louis Golmard, Steven Le Gouill, Valérie Coiteux, Reza Tabrizi, Claude-Eric Bulabois, Victoria Cacheux, Mathieu Kuentz, Brigitte Dreyfus, Peter Dreger, Bernard Rio, Marie-Pierre Moles-Moreau, Karin Bilger, Jacques-Olivier Bay, Véronique Leblond, Didier Blaise, Olivier Tournilhac, and Nathalie Dhédin |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1861136692 | ||
| 003 | DE-627 | ||
| 005 | 20240311123223.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231010s2010 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3324/haematol.2009.017814 |2 doi | |
| 035 | |a (DE-627)1861136692 | ||
| 035 | |a (DE-599)KXP1861136692 | ||
| 035 | |a (OCoLC)1425873605 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Garnier, Alice |e VerfasserIn |0 (DE-588)1020493976 |0 (DE-627)688148328 |0 (DE-576)360576621 |4 aut | |
| 245 | 1 | 0 | |a Allogeneic hematopoietic stem cell transplantation allows long-term complete remission and curability in high-risk Waldenström’s macroglobulinemia |b results of a retrospective analysis of the Société Française de Greffe de Moelle et de Thérapie Cellulaire |c Alice Garnier, Marie Robin, Fabrice Larosa, Jean-Louis Golmard, Steven Le Gouill, Valérie Coiteux, Reza Tabrizi, Claude-Eric Bulabois, Victoria Cacheux, Mathieu Kuentz, Brigitte Dreyfus, Peter Dreger, Bernard Rio, Marie-Pierre Moles-Moreau, Karin Bilger, Jacques-Olivier Bay, Véronique Leblond, Didier Blaise, Olivier Tournilhac, and Nathalie Dhédin |
| 264 | 1 | |c June, 2010 | |
| 300 | |a 6 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 10.10.2023 | ||
| 520 | |a Background Patients with poor-risk Waldenström’s macroglobulinemia have suboptimal response and early post-treatment relapse with conventional therapies. Hence, new therapeutic approaches such as allogeneic stem cell transplantation should be evaluated in these patients.Design and Methods We examined the long-term outcome of allogeneic stem cell transplantation in Waldenström’s macroglobulinemia by studying the records of 24 patients reported in the SFGM-TC database and one transplanted in the bone marrow unit in Hamburg.Results Median age at the time of transplant was 48 years (range, 24-64). The patients had previously received a median of 3 lines of therapy (range, 1-6) and 44% of them had refractory disease at time of transplant. Allogeneic stem cell transplantation after myeloablative (n=12) or reduced-intensity (n=13) conditioning yielded an overall response rate of 92% and immunofixation-negative complete remission in 50% of evaluable patients. With a median follow-up of 64 months among survivors (range, 11-149 months), 5-year overall survival and progression-free survival rates were respectively, 67% (95% CI: 46-81) and 58% (95% CI: 38-75). The 5-year estimated risk of progression was 25% (95% CI: 10-36%), with only one relapse among the 12 patients who entered complete remission, versus 5 in the 12 patients who did not. Only one of the 6 relapses occurred more than three years post-transplant.Conclusions Allogeneic stem cell transplantation yields a high rate of complete remissions and is potentially curative in poor-risk Waldenström’s macroglobulinemia. | ||
| 700 | 1 | |a Robin, Marie |e VerfasserIn |0 (DE-588)1162362154 |0 (DE-627)1026030668 |0 (DE-576)507384253 |4 aut | |
| 700 | 1 | |a Larosa, Fabrice |e VerfasserIn |4 aut | |
| 700 | 1 | |a Golmard, Jean-Louis |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gouill, Steven Le |e VerfasserIn |4 aut | |
| 700 | 1 | |a Coiteux, Valérie |e VerfasserIn |4 aut | |
| 700 | 1 | |a Tabrizi, Reza |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bulabois, Claude-Eric |e VerfasserIn |4 aut | |
| 700 | 1 | |a Cacheux, Victoria |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kuentz, Mathieu |e VerfasserIn |4 aut | |
| 700 | 1 | |a Dreyfus, Brigitte |e VerfasserIn |4 aut | |
| 700 | 1 | |a Dreger, Peter |e VerfasserIn |0 (DE-588)1028891881 |0 (DE-627)732699894 |0 (DE-576)376320966 |4 aut | |
| 700 | 1 | |a Rio, Bernard |e VerfasserIn |4 aut | |
| 700 | 1 | |a Moles-Moreau, Marie-Pierre |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bilger, Karin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bay, Jacques-Olivier |e VerfasserIn |4 aut | |
| 700 | 1 | |a Leblond, Véronique |e VerfasserIn |4 aut | |
| 700 | 1 | |a Blaise, Didier |d 1955- |e VerfasserIn |0 (DE-588)1261106237 |0 (DE-627)1834173612 |4 aut | |
| 700 | 1 | |a Tournilhac, Olivier |e VerfasserIn |4 aut | |
| 700 | 1 | |a Dhédin, Nathalie |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Haematologica, the hematology journal |d Pavia : Ferrata Storti Foundation, 2005 |g 95(2010), 6 vom: Juni, Seite 950-955 |h Online-Ressource |w (DE-627)48524375X |w (DE-600)2186022-1 |w (DE-576)414771095 |x 1592-8721 |7 nnas |a Allogeneic hematopoietic stem cell transplantation allows long-term complete remission and curability in high-risk Waldenström’s macroglobulinemia results of a retrospective analysis of the Société Française de Greffe de Moelle et de Thérapie Cellulaire |
| 773 | 1 | 8 | |g volume:95 |g year:2010 |g number:6 |g month:06 |g pages:950-955 |g extent:6 |a Allogeneic hematopoietic stem cell transplantation allows long-term complete remission and curability in high-risk Waldenström’s macroglobulinemia results of a retrospective analysis of the Société Française de Greffe de Moelle et de Thérapie Cellulaire |
| 856 | 4 | 0 | |u https://doi.org/10.3324/haematol.2009.017814 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://haematologica.org/article/view/5632 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20231010 | ||
| 993 | |a Article | ||
| 994 | |a 2010 | ||
| 998 | |g 1028891881 |a Dreger, Peter |m 1028891881:Dreger, Peter |d 910000 |d 910100 |e 910000PD1028891881 |e 910100PD1028891881 |k 0/910000/ |k 1/910000/910100/ |p 12 | ||
| 999 | |a KXP-PPN1861136692 |e 4383186238 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"recId":"1861136692","origin":[{"dateIssuedKey":"2010","dateIssuedDisp":"June, 2010"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"physDesc":[{"extent":"6 S."}],"id":{"eki":["1861136692"],"doi":["10.3324/haematol.2009.017814"]},"note":["Gesehen am 10.10.2023"],"relHost":[{"note":["Gesehen am 27.09.2018"],"disp":"Allogeneic hematopoietic stem cell transplantation allows long-term complete remission and curability in high-risk Waldenström’s macroglobulinemia results of a retrospective analysis of the Société Française de Greffe de Moelle et de Thérapie CellulaireHaematologica, the hematology journal","id":{"issn":["1592-8721"],"zdb":["2186022-1"],"eki":["48524375X"]},"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisher":"Ferrata Storti Foundation","dateIssuedDisp":"2005-2013","dateIssuedKey":"2005","publisherPlace":"Pavia"}],"recId":"48524375X","type":{"media":"Online-Ressource","bibl":"periodical"},"part":{"year":"2010","text":"95(2010), 6 vom: Juni, Seite 950-955","volume":"95","extent":"6","pages":"950-955","issue":"6"},"language":["eng"],"title":[{"title":"Haematologica, the hematology journal","subtitle":"official organ of the European Hematology Association","title_sort":"Haematologica, the hematology journal"}],"pubHistory":["90.2005 - 98.2013"]}],"name":{"displayForm":["Alice Garnier, Marie Robin, Fabrice Larosa, Jean-Louis Golmard, Steven Le Gouill, Valérie Coiteux, Reza Tabrizi, Claude-Eric Bulabois, Victoria Cacheux, Mathieu Kuentz, Brigitte Dreyfus, Peter Dreger, Bernard Rio, Marie-Pierre Moles-Moreau, Karin Bilger, Jacques-Olivier Bay, Véronique Leblond, Didier Blaise, Olivier Tournilhac, and Nathalie Dhédin"]},"person":[{"display":"Garnier, Alice","role":"aut","given":"Alice","family":"Garnier"},{"role":"aut","given":"Marie","display":"Robin, Marie","family":"Robin"},{"given":"Fabrice","role":"aut","display":"Larosa, Fabrice","family":"Larosa"},{"given":"Jean-Louis","role":"aut","display":"Golmard, Jean-Louis","family":"Golmard"},{"given":"Steven Le","role":"aut","display":"Gouill, Steven Le","family":"Gouill"},{"display":"Coiteux, Valérie","role":"aut","given":"Valérie","family":"Coiteux"},{"given":"Reza","role":"aut","display":"Tabrizi, Reza","family":"Tabrizi"},{"family":"Bulabois","display":"Bulabois, Claude-Eric","given":"Claude-Eric","role":"aut"},{"given":"Victoria","role":"aut","display":"Cacheux, Victoria","family":"Cacheux"},{"family":"Kuentz","display":"Kuentz, Mathieu","role":"aut","given":"Mathieu"},{"display":"Dreyfus, Brigitte","given":"Brigitte","role":"aut","family":"Dreyfus"},{"display":"Dreger, Peter","role":"aut","given":"Peter","family":"Dreger"},{"family":"Rio","role":"aut","given":"Bernard","display":"Rio, Bernard"},{"family":"Moles-Moreau","display":"Moles-Moreau, Marie-Pierre","role":"aut","given":"Marie-Pierre"},{"family":"Bilger","role":"aut","given":"Karin","display":"Bilger, Karin"},{"display":"Bay, Jacques-Olivier","given":"Jacques-Olivier","role":"aut","family":"Bay"},{"family":"Leblond","display":"Leblond, Véronique","given":"Véronique","role":"aut"},{"display":"Blaise, Didier","given":"Didier","role":"aut","family":"Blaise"},{"display":"Tournilhac, Olivier","given":"Olivier","role":"aut","family":"Tournilhac"},{"role":"aut","given":"Nathalie","display":"Dhédin, Nathalie","family":"Dhédin"}],"title":[{"title_sort":"Allogeneic hematopoietic stem cell transplantation allows long-term complete remission and curability in high-risk Waldenström’s macroglobulinemia","subtitle":"results of a retrospective analysis of the Société Française de Greffe de Moelle et de Thérapie Cellulaire","title":"Allogeneic hematopoietic stem cell transplantation allows long-term complete remission and curability in high-risk Waldenström’s macroglobulinemia"}],"language":["eng"]} | ||
| SRT | |a GARNIERALIALLOGENEIC2010 | ||